MiNK Therapeutics shows dual immune responses from single cell therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to MiNK Therapeutics shows dual immune responses from single cell therapy
(NASDAQ: INKT) Delayed: 12.25 +0.11 (0.91%)
Previous Close $12.14    52 Week High $ 
Open $12.33    52 Week Low $ 
Day High $12.51    P/E N/A 
Day Low $12.01    EPS $ 
Volume 19,823